Dr. Steven Sears, D.O.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Arizona College of Medicine (2019)
- Years since graduation
- 7
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 159
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Medical school: University of Arizona College of Medicine
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
OR license DO192244 · AZ license R2671 -
Critical Care Medicine (Internal Medicine) Physician
AZ license R2671 -
Internal Medicine Physician
FL license OS12369 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ohsu Hospital and Clinics Portland, OR
- Legacy Good Samaritan Medical Center Portland, OR
- Legacy Meridian PArk Medical Center Tualatin, OR
- Legacy Emanuel Medical Center Portland, OR
- Columbia Memorial Hospital Astoria, OR
Medical groups
- Legacy Clinics LLC (713 clinicians)
- Legacy Good Samaritan Hospital and Medical Center (191 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 159
- Services billed
- 444
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 102 | 55 |
| Established patient office or other outpatient visit, 40-54 minutes | 59 | 39 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 32 | 18 |
| Established patient office or other outpatient visit, 30-39 minutes | 30 | 28 |
| New patient office or other outpatient visit, 60-74 minutes | 18 | 18 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 13 | 13 |
| Insertion of tube in right heart chambers for measurement | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Portland, OR | 106 |
| Prednisone Other prescribers in Portland, OR | 98 |
| Uptravi (selexipag) | 91 |
| Potassium Chloride Other prescribers in Portland, OR | 71 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Portland, OR | 62 |
| Furosemide Other prescribers in Portland, OR | 61 |
| Tadalafil | 55 |
| Sildenafil Citrate Other prescribers in Portland, OR | 52 |
| Opsumit (macitentan) | 48 |
| Tyvaso Dpi (treprostinil) | 46 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 13 payments worth $19,571 in total to this clinician.
| United Therapeutics Corporation | $19,519 |
|---|---|
| Actelion Pharmaceuticals US, Inc. | $26.10 |
| Merck Sharp & Dohme LLC | $25.70 |
| Compensation for services other than consulting (speaking, faculty) | $17,490 |
|---|---|
| Travel and Lodging | $1,750 |
| Food and Beverage | $304 |
| Education | $25.70 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| United Therapeutics Corporation Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $11,550 |
| United Therapeutics Corporation Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,940 |
| United Therapeutics Corporation Feb 28, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $608 |
| United Therapeutics Corporation Feb 6, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $597 |
| United Therapeutics Corporation Aug 25, 2025 | Travel and Lodging travel to Spokane, WA · in-kind | $333 |
| United Therapeutics Corporation Oct 9, 2025 | Travel and Lodging travel to Spokane, WA · in-kind | $212 |
| Merck Sharp & Dohme LLC Jul 31, 2025 | Education WINREVAIR · CARDIOVASCULAR · in-kind | $25.70 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $51,628 in research payments for these studies, mostly to the institutions running them.
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
United Therapeutics Corporation · Recruiting · NCT06388421 - Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
United Therapeutics Corporation · Completed · NCT05776225 - BAY 632521, RiOciguAt UseRs Registry The ROAR registry
Bayer HealthCare Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.